Endurant Capital Management LP - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 68 filers reported holding OCULAR THERAPEUTIX INC in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 1.1%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$1,110,640
-41.6%
353,707
-4.0%
1.00%
-39.9%
Q2 2023$1,901,140
-29.6%
368,438
-28.1%
1.66%
+19.6%
Q1 2023$2,702,161
-9.6%
512,744
-51.8%
1.39%
+14.3%
Q4 2022$2,989,708
-32.3%
1,063,953
-0.0%
1.21%
-15.6%
Q3 2022$4,417,000
+44.5%
1,064,295
+40.0%
1.44%
+34.2%
Q2 2022$3,056,000
-33.2%
760,228
-17.7%
1.07%
-11.0%
Q1 2022$4,574,000
-8.5%
923,963
+28.8%
1.20%
-0.1%
Q4 2021$4,998,000
-18.1%
717,143
+17.5%
1.21%
-13.2%
Q3 2021$6,104,000
-24.6%
610,401
+6.9%
1.39%
-37.5%
Q2 2021$8,096,000
+12.4%
570,970
+30.1%
2.22%
+18.5%
Q1 2021$7,203,000
+19.8%
438,933
+51.1%
1.88%
-13.4%
Q4 2020$6,013,000
-5.6%
290,465
-65.3%
2.17%
+15.1%
Q3 2020$6,371,000
+1.3%
837,137
+10.8%
1.88%
+446.1%
Q2 2020$6,292,000
+121.3%
755,330
+5.5%
0.34%
-69.3%
Q1 2019$2,843,000
+207.0%
716,124
+207.7%
1.12%
+129.9%
Q4 2018$926,000
-55.5%
232,727
-23.0%
0.49%
-47.1%
Q3 2018$2,079,000
+115.7%
302,153
+111.6%
0.92%
+121.3%
Q2 2018$964,000
-17.0%
142,775
-20.0%
0.42%
-3.7%
Q1 2018$1,162,000178,4610.43%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2018
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$32,263100.00%
Opaleye Management Inc. 6,105,900$32,178,0939.64%
DELTEC ASSET MANAGEMENT LLC 1,913,612$10,084,7352.49%
Knoll Capital Management, LLC 200,000$1,504,0002.32%
Endurant Capital Management LP 512,744$2,702,1611.39%
Knoll Capital Management, LLC 95,800$504,8660.78%
Covestor Ltd 60,008$3160.28%
Ikarian Capital, LLC 200,000$1,054,0000.24%
EAM Investors, LLC 224,211$1,181,5920.23%
Nebula Research & Development LLC 22,474$118,4380.21%
View complete list of OCULAR THERAPEUTIX INC shareholders